Immunomodulatory properties of human placental mesenchymal stem/stromal cells
Immunomodulatory properties of human placental mesenchymal stem/stromal cells
复制标题
DOI：
10.1016/j.placenta.2017.04.003
复制
发表时间：
2017-11-01
期刊：
影响因子：
3.8
通讯作者：
Kalionis, B.
中科院分区：
文献类型：
--
作者：
Abumaree, M. H.;Abomaray, F. M.;Kalionis, B.
Mesenchymal stem/stromal cells (MSCs) are isolated from various fetal and adult tissues such as bone marrow, adipose tissue, cord blood and placenta. Placental MSCs (pMSCs), the main focus of this review, are relatively new MSC types that are not as intensively studied compared with bone marrow-derived MSCs (BMMSCs). MSCs modulate the immune functions of important immune cells involved in alloantigen recognition and elimination, including antigen presenting cells (APCs), T cells, B cells and natural killer (NK) cells. Clinical trials, both completed and underway, employ MSCs to treat various human immunological diseases, such as multiple sclerosis (MS) and type 1 diabetes. However, the mechanisms that mediate the immunosuppressive effects of pMSCs are still largely unknown, and the safety of pMSC use in clinical settings needs further confirmation. Here, we review the current knowledge of the immunosuppressive properties of placental MSCs. (C) 2017 Elsevier Ltd. All rights reserved.
